FDA inspection
Paramesh Banerji Life Sciences, LLC: FDA inspection ending Sep 24, 2021
FDA inspection 1152923 · Official Action Indicated (OAI) · North Brunswick, NJ
Key facts
| Inspection ID | 1152923 |
|---|---|
| Firm | Paramesh Banerji Life Sciences, LLC |
| FEI number | 3011020725 |
| Address | 220 N Center Dr |
| City | North Brunswick |
| State | NJ |
| ZIP | 08902 |
| Country | United States |
| Fiscal year | 2021 |
| Inspection end date | Sep 24, 2021 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data